SEMASEARCH Study Design: Real‐World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials

Pierre Bel Lassen, David Jacobi, Marie‐Claude Brindisi, Jean‐Baptiste Bonnet, Fabien Subtil, Sylvie Bin, Fanny Abad, Christine Poitou, Bérénice Segrestin, Séverine Ledoux, Bénédicte Gaborit, Judith Aron‐Wisnewsky, Claire Carette, Mohamed Zerguine, Blandine Gatta‐Cherifi, Didier Quilliot, Emilie Montastier, Antoine Avignon, Héléna Mosbah, Sébastien Czernichow, Emmanuel Disse

Open source

DOI: 10.1111/dom.70697
Published: 2026-03-26
Container: Diabetes, Obesity and Metabolism
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.70697,
  title = {SEMASEARCH Study Design: Real‐World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials},
  author = {Pierre Bel Lassen and David Jacobi and Marie‐Claude Brindisi and Jean‐Baptiste Bonnet and Fabien Subtil and Sylvie Bin and Fanny Abad and Christine Poitou and Bérénice Segrestin and Séverine Ledoux and Bénédicte Gaborit and Judith Aron‐Wisnewsky and Claire Carette and Mohamed Zerguine and Blandine Gatta‐Cherifi and Didier Quilliot and Emilie Montastier and Antoine Avignon and Héléna Mosbah and Sébastien Czernichow and Emmanuel Disse},
  year = {2026},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.70697},
  url = {https://doi.org/10.1111/dom.70697}
}

RIS

TY  - JOUR
TI  - SEMASEARCH Study Design: Real‐World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials
AU  - Pierre Bel Lassen
AU  - David Jacobi
AU  - Marie‐Claude Brindisi
AU  - Jean‐Baptiste Bonnet
AU  - Fabien Subtil
AU  - Sylvie Bin
AU  - Fanny Abad
AU  - Christine Poitou
AU  - Bérénice Segrestin
AU  - Séverine Ledoux
AU  - Bénédicte Gaborit
AU  - Judith Aron‐Wisnewsky
AU  - Claire Carette
AU  - Mohamed Zerguine
AU  - Blandine Gatta‐Cherifi
AU  - Didier Quilliot
AU  - Emilie Montastier
AU  - Antoine Avignon
AU  - Héléna Mosbah
AU  - Sébastien Czernichow
AU  - Emmanuel Disse
PY  - 2026
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.70697
UR  - https://doi.org/10.1111/dom.70697
ER  -

APA

Lassen, P. B., Jacobi, D., Brindisi, M., Bonnet, J., Subtil, F., Bin, S., Abad, F., Poitou, C., Segrestin, B., Ledoux, S., Gaborit, B., Aron‐Wisnewsky, J., Carette, C., Zerguine, M., Gatta‐Cherifi, B., Quilliot, D., Montastier, E., Avignon, A., Mosbah, H., Czernichow, S., & Disse, E. (2026). SEMASEARCH Study Design: Real‐World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70697

Source records

crossref · retrieved 2026-09-27T04:23:13.792Z